The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data?
Abstract
In the context of competing risks the Kaplan—Meier estimator is often unsuitable for summarizing failure time data. We discuss some alternative descriptive methods including marginal probability and conditional probability estimators. Two‐sample test statistics are also presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Counting Processes and Survival Analysis.
Dabrowska, D. M., Fleming, T. R., & Harrington, D. P. (1992) · Journal of the American Statistical Association · doi:10.2307/2290673 · Cited by 2,271
The Analysis of Failure Times in the Presence of Competing Risks
Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., & Breslow, N. E. (1978) · Biometrics · doi:10.2307/2530374 · Cited by 1,266
Cited by
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Austin, P. C., Lee, D. S., & Fine, J. P. (2016) · Circulation · doi:10.1161/circulationaha.115.017719 · Cited by 2,653
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Klampfl, T., Gisslinger, H., Harutyunyan, A. S., Nivarthi, H., Rumi, E., Milosevic, J. D., Them, N. C. C., Berg, T., Gisslinger, B., Pietra, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311347 · Cited by 2,003
Competing Risk Regression Models for Epidemiologic Data
Lau, B., Cole, S. R., & Gange, S. J. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp107 · Cited by 1,403
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Généreux, P., Piazza, N., Alu, M. C., Nazif, T., Hahn, R. T., Pibarot, P., Bax, J. J., Leipsic, J. A., Blanke, P., Blackstone, E. H., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.038 · Cited by 1,313
VARC-3 WRITING COMMITTEE, Généreux, P., Piazza, N., Alu, M. C., Nazif, T., Hahn, R. T., Pibarot, P., Bax, J. J., Leipsic, J. A., Blanke, P., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa799 · Cited by 915
A note on competing risks in survival data analysis
Satagopan, J. M., Ben-Porat, L., Berwick, M., Robson, M., Kutler, D., & Auerbach, A. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602102 · Cited by 745
Competing risk analysis using R: an easy guide for clinicians
Scrucca, L., Santucci, A., & Aversa, F. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705727 · Cited by 699
When do we need competing risks methods for survival analysis in nephrology?
Noordzij, M., Leffondre, K., van Stralen, K. J., Zoccali, C., Dekker, F. W., & Jager, K. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft355 · Cited by 669
Multi-state models for event history analysis
Andersen, P. K., & Keiding, N. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm276ra · Cited by 628
Rumi, E., Pietra, D., Ferretti, V., Klampfl, T., Harutyunyan, A. S., Milosevic, J. D., Them, N. C. C., Berg, T., Elena, C., Casetti, I. C., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539098 · Cited by 602
Competing Risk of Death: An Important Consideration in Studies of Older Adults
Berry, S. D., Ngo, L., Samelson, E. J., & Kiel, D. P. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02767.x · Cited by 593
Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding: A Randomized Trial
Sung, J. J. Y., Lau, J. Y. W., Ching, J. Y. L., Wu, J. C. Y., Lee, Y. T., Chiu, P. W. Y., Leung, V. K. S., Wong, V. W. S., & Chan, F. K. L. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-1-201001050-00179 · Cited by 520
Small, T. N., Papadopoulos, E. B., Boulad, F., Black, P., Castro-Malaspina, H., Childs, B. H., Collins, N., Gillio, A., George, D., Jakubowski, A., et al. (1999) · Blood · doi:10.1182/blood.v93.2.467 · Cited by 490
Hogan, S. L., Falk, R. J., Chin, H., Cai, J., Jennette, C. E., Jennette, J. C., & Nachman, P. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00005 · Cited by 479
Squires, R. H., Duggan, C., Teitelbaum, D. H., Wales, P. W., Balint, J., Venick, R., Rhee, S., Sudan, D., Mercer, D., Martinez, J. A., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.03.062 · Cited by 464
NON-PARAMETRIC INFERENCE FOR CUMULATIVE INCIDENCE FUNCTIONS IN COMPETING RISKS STUDIES
LIN, D. Y. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970430)16:8<901::aid-sim543>3.0.co;2-m · Cited by 445
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jädersten, M., Jansson, M., Elena, C., Gallì, A., Walldin, G., Della Porta, M. G., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633537 · Cited by 434
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
Rumi, E., Pietra, D., Pascutto, C., Guglielmelli, P., Martínez-Trillos, A., Casetti, I., Colomer, D., Pieri, L., Pratcorona, M., Rotunno, G., et al. (2014) · Blood · doi:10.1182/blood-2014-05-578435 · Cited by 394
Glynn, R. J., & Rosner, B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi309 · Cited by 380
Klein, J. P., & Andersen, P. K. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.031209.x · Cited by 349
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Kerlikowske, K., Molinaro, A. M., Gauthier, M. L., Berman, H. K., Waldman, F., Bennington, J., Sanchez, H., Jimenez, C., Stewart, K., Chew, K., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq101 · Cited by 343
Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke
Prosser, J., MacGregor, L., Lees, K. R., Diener, H.-C., Hacke, W., & Davis, S. (2007) · Stroke · doi:10.1161/strokeaha.106.471813 · Cited by 339
Darrington, D. L., Vose, J. M., Anderson, J. R., Bierman, P. J., Bishop, M. R., Chan, W. C., Morris, M. E., Reed, E. C., Sanger, W. G., & Tarantolo, S. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2527 · Cited by 332
Sanz, M. A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., de Lisa, E., Brunet, S., Rubio, V., Ribera, J. M., et al. (2010) · Blood · doi:10.1182/blood-2010-01-266007 · Cited by 328
Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma
Hanrahan, E. O., Gonzalez-Angulo, A. M., Giordano, S. H., Rouzier, R., Broglio, K. R., Hortobagyi, G. N., & Valero, V. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0499 · Cited by 315
Bandopadhayay, P., Bergthold, G., London, W. B., Goumnerova, L. C., Morales La Madrid, A., Marcus, K. J., Guo, D., Ullrich, N. J., Robison, N. J., Chi, S. N., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24958 · Cited by 313
Bell, J., Brady, M. F., Young, R. C., Lage, J., Walker, J. L., Look, K. Y., Rose, G. S., & Spirtos, N. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.013 · Cited by 307
Kawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., & Kaku, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60222-1 · Cited by 303
Jaroscak, J., Goltry, K., Smith, A., Waters-Pick, B., Martin, P. L., Driscoll, T. A., Howrey, R., Chao, N., Douville, J., Burhop, S., et al. (2003) · Blood · doi:10.1182/blood-2001-12-0290 · Cited by 302
Warner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., Foulkes, W. D., Ghadirian, P., Lynch, H., Couch, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0835 · Cited by 280
Klein, J., Rizzo, J., Zhang, M.-J., & Keiding, N. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703260 · Cited by 278
Probabilities of Death From Breast Cancer and Other Causes Among Female Breast Cancer Patients
Schairer, C., Mink, P. J., Carroll, L., & Devesa, S. S. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh253 · Cited by 275
Nonparametric Analysis of Recurrent Events and Death
Ghosh, D., & Lin, D. Y. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00554.x · Cited by 272
Outcomes of ABO-Incompatible Kidney Transplantation in the United States
Montgomery, J. R., Berger, J. C., Warren, D. S., James, N. T., Montgomery, R. A., & Segev, D. L. (2012) · Transplantation · doi:10.1097/tp.0b013e318245b2af · Cited by 270
Choice and Interpretation of Statistical Tests Used When Competing Risks Are Present
Dignam, J. J., & Kocherginsky, M. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9866 · Cited by 268
Griffin, K. A., Hebblewhite, M., Robinson, H. S., Zager, P., Barber-Meyer, S. M., Christianson, D., Creel, S., Harris, N. C., Hurley, M. A., Jackson, D. H., et al. (2011) · Journal of Animal Ecology · doi:10.1111/j.1365-2656.2011.01856.x · Cited by 201
How to handle mortality when investigating length of hospital stay and time to clinical stability
Brock, G. N., Barnes, C., Ramirez, J. A., & Myers, J. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-144 · Cited by 138
Schaffer, J. M., Singh, S. K., Joyce, D. L., Reitz, B. A., Robbins, R. C., Zamanian, R. T., & Mallidi, H. R. (2013) · Circulation · doi:10.1161/circulationaha.112.001080 · Cited by 69
Klaassen, Z., Wallis, C. J. D., Chandrasekar, T., Goldberg, H., Sayyid, R. K., Williams, S. B., Moses, K. A., Terris, M. K., Nam, R. K., Urbach, D., et al. (2019) · Cancer · doi:10.1002/cncr.32146 · Cited by 63
Metadata
- Authors
- Pepe, M. S., & Mori, M.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 1993-04-30
- Volume
- 12
- Issue
- 8
- Pages
- 737-751
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W1965359675
- Cited by
- 620
- References
- 19
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.